Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Reg FD DisclosureItem 7.01 · 8-KLOW RiskNeutral

CV Sciences, Inc.

cvsciences.com
Filed: Mar 26, 2026San DiegoCIK: 0001510964Other
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

CV Sciences, Inc. announced its financial results for fiscal year 2025 on March 26, 2026, providing both GAAP and non-GAAP financial measures to inform shareholders of operational performance and strategic positioning.

Key Takeaways

Company disclosed FY 2025 financial results including both GAAP and non-GAAP measures with reconciliations

Filing demonstrates commitment to transparency and detailed financial reporting to shareholders

2 more takeaways

Filing Overview

Form Type8-K
Filing DateMar 26, 2026
Item7.01
CategoryReg FD Disclosure
CIK0001510964
Accession #0001510964
Risk LevelLOW
SentimentNeutral
Signalinformational
Topics
earnings

What This Means

The company is making a public disclosure under Regulation FD, often sharing material information to ensure equal access.
View Full Filing on SEC.govBrowse More Filings